| Model Number |
442192 |
| Medical Device Problem Code |
False Positive Result (1227)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
09/09/2021
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Multiple lot numbers: there were multiple lot numbers reported to be involved.The information for additional lot number is as follows: medical device lot #: 1181309, medical device expiration date: 2022-04-30, device manufacture date: 2021-06-30.There were multiple 510k numbers reported to be involved.The information for the additional 510k is as follows: pma / 510(k)#: k921133.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
| |
|
Event or Problem Description
|
|
It was reported with testing patient samples with bd bactec¿ plus aerobic/f culture vials using the biofire 4 samples detected acinetobacter.Cultures did not grow out acinetobater.Patient impact was not reported.The following information was provided by the initial reporter: it was reported that bactec samples with discrepant results using biofire.
|
| |
|
Additional Manufacturer Narrative
|
|
Investigation summary: customer reported a positive id result for bactec media, while using biofire filmarray® blood culture identification bdic/bcid2 panels.Bd was unable to reproduce the customer¿s experience with the bactec product based on our internal procedures and the intended use of the product.Retention samples were visually inspected, tested for viable contamination by sub-culturing on tsa, chocolate, sabouraud and schaedler agars plates, voltage output and gram stain.All results were satisfactory.Batch history record review did not identify any evidence for which the customer submitted the complaint.A complaint history review was conducted and only the current complaint was found relating to the incident lot number and the ¿as reported¿ defect code.Complaint is unconfirmed based on retention samples and batch history record review results.As per product insert a gram-stained smear from culture medium may contain small numbers of nonviable organisms derived from media constituents, staining reagents, immersion oil, glass slides, and specimens used for inoculation.Due to the nature of biological materials in media products and inherent organism variability, the user should be cognizant of potential variable results in the recovery of certain microorganisms.Molecular tests performed on positive blood cultures will detect both viable and non-viable organisms commonly found in culture media.Therefore, molecular test results should be evaluated in conjunction with gram stain results in accordance with standard-of-care practices as well as manufacturer¿s instructions for use.No corrective actions were required.A cross functional team continually monitors all product complaints for trends and determines if any additional actions are necessary beyond the current investigational process.
|
| |
|
Event or Problem Description
|
|
It was reported with testing patient samples with bd bactec¿ plus aerobic/f culture vials using the biofire 4 samples detected acinetobacter.Cultures did not grow out acinetobater.Patient impact was not reported.The following information was provided by the initial reporter: it was reported that bactec samples with discrepant results using biofire.
|
| |
|
Search Alerts/Recalls
|